Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Meeting Calendar
  3. Past Meetings
  4. ESMO Congress 2024
  5. Satellite Symposia Webcasts

Merck Healthcare KGaA - Sequencing is Key: Unlocking Individualized Treatment in Bladder Cancer

Navigating first-line treatment approaches in la/mUC

Date

14 Sep 2024

Session

Merck Healthcare KGaA - Sequencing is Key: Unlocking Individualized Treatment in Bladder Cancer

Topics

Targeted Therapy;  Immunotherapy

Tumour Site

Urothelial Cancer

Presenters

Alison Birtle

Authors

A.J. Birtle

Author affiliations

  • Rosemere Cancer Centre, Royal Preston Hospital, PR2 9HT - Preston/GB

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome and introduction

Presenter: Enrique Grande

Session: Merck Healthcare KGaA - Sequencing is Key: Unlocking Individualized Treatment in Bladder Cancer

Resources:

Webcast

Audience Q&A

Presenter: Enrique Grande, Syed Hussain, Philippe Barthelemy, Alison Birtle

Session: Merck Healthcare KGaA - Sequencing is Key: Unlocking Individualized Treatment in Bladder Cancer

Resources:

Webcast

Closing Remarks

Presenter: Enrique Grande

Session: Merck Healthcare KGaA - Sequencing is Key: Unlocking Individualized Treatment in Bladder Cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.